After completing her Master’s degree in Molecular and Cellular Biology at the University of Bern, Julia sought to enter the pharmaceutical industry and gain valuable experience in the field. Her journey began at Lonza, where she joined the Microbial DSP Process Development team, gaining her first experience in biotechnology. This initial exposure fueled her passion for downstream processes.
Over the course of eight years in the biotechnology industry, Julia was able to deepen her expertise in DSP by working on various projects. She developed and optimized microbial and mammalian DSP processes and was involved in the conceptual design of a GMP multipurpose facility and laboratory spaces. Additionally, her career provided her with a valuable opportunity to engage with viral vectors, as she supported the gene and cell therapy research and process development teams.
In February 2023, Julia started an exciting Ph.D. project at the FHNW, which combines two of her core interests: developing DSP processes and working with viral vectors. In collaboration with her industrial partner, YMC ChromaCon, she is dedicated to the development of continuous purification strategies for plasmids and adeno-associated viruses (AAVs), both of which play a crucial role in the emerging field of gene therapy.